Despite being a pan-kinase inhibitor, OTSSP167 targeted other pathways besides MAP2K7-JNK, such as mTOR and NOTCH1, in T-ALL cells (65). The gene discussed is MAP2K7; the disease is acute lymphoblastic leukemia.